Long-term follow-up of acute lymphoblastic leukemia in young children treated by the SCMC-ALL-2009 protocol-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term follow-up of acute lymphoblastic leukemia in young children treated by the SCMC-ALL-2009 protocol

Published:2020-07-09 Issue:12 Volume:61 Page:2850-2858
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Liu Kangkang¹^ORCID,Chu Jinhua¹,Dai Yu¹²,Jiang Aoshuang¹³,Yang Linhai¹,Xie Zhiwei¹,Zhang Kunlong¹,Tu Songji¹,Cai Huaju¹,Wu Zhengyu¹,Wang Ningling¹

Affiliation:

1. Department of Pediatrics, The Second Hospital of Anhui Medical University, Hefei, China

2. Department of Pediatrics, The Fourth Hospital of Anhui Medical University, Hefei, China

3. Hematology Department, Anhui Provincial Children’s Hospital, Hefei, China

Funder

Scientific Research Foundation of Anhui Medical University

the Grants for Scientific Research of the Second Hospital of Anhui Medical University

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1786557

Reference29 articles.

1. Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience

2. Treatment of Acute Lymphoblastic Leukemia

3. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study

4. Long‐term outcome of childhood acute lymphoblastic leukemia treated in China

5. Treatment outcome of young children with acute lymphoblastic leukaemia: achievements and directions implied from Shanghai Children's Medical Centre based SCMC-ALL-2005 protocol

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse;Nature Cancer;2021-07-22

2. Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysis;Annals of Hematology;2021-02-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3